Walleye Capital LLC Amicus Therapeutics, Inc. Transaction History
Walleye Capital LLC
- $38.9 Billion
- Q4 2024
A detailed history of Walleye Capital LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 18,000 shares of FOLD stock, worth $165,600. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,000
Previous 58,600
69.28%
Holding current value
$165,600
Previous $625,000
72.96%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding FOLD
# of Institutions
312Shares Held
311MCall Options Held
467KPut Options Held
515K-
Vanguard Group Inc Valley Forge, PA29.3MShares$269 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA28.5MShares$262 Million0.05% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$224 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY24.2MShares$223 Million7.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$213 Million3.18% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.58B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...